Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) Stock Short Interest Report for October

Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) was the recipient of a significant increase in short interest in the month of October. As of October 30th, there was short interest totaling 2,838 shares, an increase of 1,319.0% from the October 15th total of 200 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily volume of 2,344 shares, the days-to-cover ratio is presently 1.2 days.

Santen Pharmaceutical Price Performance

SNPHY stock remained flat at $12.67 on Thursday. The company had a trading volume of 291 shares, compared to its average volume of 2,199. The company has a 50-day moving average price of $11.18 and a two-hundred day moving average price of $11.53. Santen Pharmaceutical has a 12 month low of $9.50 and a 12 month high of $13.93.

Santen Pharmaceutical Company Profile

Santen Pharmaceutical is a Japan-based pharmaceutical company focused on eye care. Founded in 1890, it researches, develops, manufactures and markets treatments for ophthalmic conditions. Its products include prescription medicines for conditions such as glaucoma, dry eye and retinal diseases, as well as over-the-counter eye drops and other eye-care products. The company also offers products for eye surgery and related medical needs. Headquartered in Osaka, Santen serves patients and healthcare professionals in Japan and international markets, including other parts of Asia, Europe and the Middle East and Africa.